Bioresorbable Medical Material Market Growth by 2027 Involving Prominent Players Such as Evonik. Foster, Poly-Med

Polylactide (PLA)Segment byProductType Is Expected toDominate the MarketOver the Forecast Period

According to The Insight Partners market research study of ‘Bioresorbable Medical Material Market to 2027 – Global Analysis and Forecasts by Product Type andApplication.’

The global bioresorbable medical material market is expected to reach US$ 1,942.13 Mn in 2027 from US$ 935.99 Mn in 2019. The market is estimated to grow with a CAGR of 9.7% from 2020-2027.The report provides trends prevailing in the global bioresorbable medical materialmarketand the factors driving market along with those that act as hindrances.

The bioresorbable medical material market, by product type, is segmented into Polylactide (PLA), Poly-L-lactide (PLLA), Poly-DL-lactide (PDLLA), Polyglycolide (PGA), and Copolymers of PLA and PGA (PGLA). The polylactide(PLA) segment held the largest share of the market in 2019 however the poly-DL-lactide (PDLLA) segment isanticipated to register the highest CAGR of 11.1% in the market during the forecast period.Due to the excellent mechanical properties and biocompatibility, PLA is used in various medical fields such as drug delivery systems and medical implants. PLAis also widely used in tissue engineering, and it finds a wide spectrum of applications in the medical field.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00008231/                    

Market Insights

Increasing number of orthopedic surgeries

The rise in ageing population is consequently leading to increase in the total number of orthopedic procedures performed worldwide. In addition, the significant advancements in the field of orthopedic science have also helped in conduction of better and efficient surgical procedures leading to their increasing adoption. The uses of biodegradable polymers that are used to produce bioresorbable implants have also witnessed a rise in their adoption. According to a report by Becker’s Hospital, the total number of orthopedic surgeries performed in the US is expected to reach 6.6 million in 2020 as compared to 5.3 performed in 2010. Moreover, according to the American Society of Orthopedic Surgeons (AAOS), a full-time practicing orthopedic surgeon performs approximately 32 surgeries each month, which averages to more than one surgery performed per day.

Also, The American Academy of Orthopedic Surgeons stated that 126.6 million Americans have a musculoskeletal condition. Therefore, increasing orthopedic surgeries coupled with benefits of bioresorbable medical material to treat the musculoskeletal diseases and orthopedic injuries is likely to boost the demand for bioresorbable medical material during the forecast period.

Product TypeInsights

The bioresorbable medical material market, by product type, is segmented into Polylactide (PLA), Poly-L-lactide (PLLA), Poly-DL-lactide (PDLLA), Polyglycolide (PGA), and Copolymers of PLA and PGA (PGLA). The polylactide (PLA) segment held the largest share of the market in 2019 however the poly-DL-lactide (PDLLA) segment is anticipated to register the highest CAGR in the market during the forecast period.Due to the excellent mechanical properties and biocompatibility, PLA is used in various medical fields such as drug delivery systems and medical implants. PLA is also widely used in tissue engineering, and it finds a wide spectrum of applications in the medical field.

The growth of the market is attributed to some key driving factors such as increasing number of orthopedic surgeries, growinggeriatric population and rising adoption of bioresorbable polymers for medical use. However, challengesassociated with the use of bioresorbable materials for medical use and bassinet on global business due tocoronavirus pandemic are expected to restraint the growth of the market during the forecast years.

Leading companies operating in the bioresorbable medical material marketare Evonik. Foster Corporation, Poly-Med Corporation, Zeus Industrial Products, Inc., Ashland, Durect Corporation, Groupe PCAS, DSM,Corbion, and Putnam Plastics among others. The companies are focused towards adoption of organic strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in August 2019, Meril Life Sciences received CE marking for 100-micron bioresorbable scaffold that was indigenously designed, developed and manufactured inIndia.

Purchase this Premium Report at https://www.theinsightpartners.com/buy/TIPRE00008231/            

Contact Us

Contact Person: Content Team

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com